News

A US startup company is offering to help wealthy couples screen their embryos for IQ using controversial technology that raises questions about the ethics of genetic enhancement.

The company, Heliospect Genomics, has worked with more than a dozen couples undergoing...

A little-noticed change to South Africa’s national health research guidelines, published in May of this year, has put the country on an ethical precipice. The newly added language appears to position the country as the first to explicitly permit...

IN THE FALL OF 2016, I gave a talk at the Institute for Advanced Study in Princeton titled “Are Robots...

Discovering your genetic history can be as simple as spitting into a test tube, but what happens when your data...

By Ben Spencer, The Times | 11.28.2021

IVF clinics selling ineffective “add-on” treatments face fines as part of the biggest shake-up of fertility laws in 30 years...

By Isabella Cueto, STAT | 11.26.2021

A common in vitro fertilization procedure offered to patients with the promise of increasing their likelihood of successful pregnancy actually does...

By Grace Browne, Wired UK | 11.25.2021

IN NOVEMBER 2019, Matt Hancock, then the United Kingdom’s health secretary, unveiled a lofty ambition: to sequence the genome of...

Baby crawling within a DNA helix
By Vivien Marx, Nature Biotechnology | 11.24.2021

Three years after the ‘CRISPR babies’ burst into the public eye and caused outrage, their fate remains shrouded in secrecy...

By Vicky Spratt, Refinery29 | 11.22.2021

There is increasing concern among the medical community that the high doses of hormones involved in fertility treatments – whether...

David Liu
By Allison DeAngelis, Insider | 11.22.2021

Photo from Beam Therapeutics

David Liu is best known as one of the pioneers of the experimental science of editing...

FDA building
By Damian Garde, STAT | 11.19.2021

The Food and Drug Administration approved the first treatment for the most common cause of dwarfism Friday, a drug that...

Turquoise-colored chromosomes
By Claire Robinson, GMWatch | 11.19.2021

In another of a long line of studies showing unintended effects of gene editing, the CRISPR-Cas gene editing tool has...